What do Canadian uro-oncologists believe patients should know about androgen deprivation therapy?

Tran, Susan H; Walker, Lauren M.; Wassersug, Richard J.; Matthew, Andrew; McLeod, Deborah; Robinson, John W.

doi:10.1177/1078155213495285

Cited by 16 publications

(15 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Even for those that do have management strategies, there is considerable variability in the quality of supporting research, as well as in the collective opinion of health care professionals about which strategies should be endorsed (eg, behavioral strategies, lifestyle changes, medication management). 93 It is recommended that interested readers consult the following excellent review articles for information about management strategies: Moyad and Roach, 74 Mohile et al, 94 Elliot et al, 42 Flaig and Glode, 95 Grossman and Zajac, 96,97 and Kim and Freedland. 98 Strategies to Attenuate the Effects of LHRHa Various methods of ADT can significantly impact side effect profiles.…”

Section: Management Strategiesmentioning

confidence: 99%

Luteinizing Hormone–Releasing Hormone Agonists: A Quick Reference for Prevalence Rates of Potential Adverse Effects

Walker

Tran

Robinson

2013

Clinical Genitourinary Cancer

Self Cite

View full text Add to dashboard Cite

Section: Management Strategiesmentioning

confidence: 99%

Luteinizing Hormone–Releasing Hormone Agonists: A Quick Reference for Prevalence Rates of Potential Adverse Effects

Walker

Tran

Robinson

2013

Clinical Genitourinary Cancer

Self Cite

View full text Add to dashboard Cite

“…A urologist or a nurse specializing in uro-oncology patient care oversees the physical health of the patients, and a clinical psychologist manages the clinical and research agendas. The sexual health counsellors are psychology residents who have completed coursework in sexual health and cancer (for example, ipode and sharetraining) 33,34 . Additionally, to reinforce "real world" experience, the sexual health counsellors shadow and are shadowed for several months by senior pcrc staff.…”

Section: Personnel and Staffingmentioning

confidence: 99%

The Prostate Cancer Rehabilitation Clinic: A Biopsychosocial Clinic for Sexual Dysfunction after Radical Prostatectomy

et al. 2018

View full text Add to dashboard Cite

Purpose The most prevalent intervention for localized prostate cancer (pca) is radical prostatectomy (rp), which has a 10-year relative survival rate of more than 90%. The improved survival rate has led to a focus on reducing the burden of treatment-related morbidity and improving the patient and partner survivorship experience. Post-rp sexual dysfunction (sdf) has received significant attention, given its substantial effect on patient and partner health-related quality of life. Accordingly, there is a need for sdf treatment to be a fundamental component of pca survivorship programming.Methods Most research about the treatment of post-rp sdf involves biomedical interventions for erectile dysfunction (ed). Although findings support the effectiveness of pro-erectile agents and devices, most patients discontinue use of such aids within 1 year after their rp. Because side effects of pro-erectile treatment have proved to be inadequate in explaining the gap between efficacy and ongoing use, current research focuses on a biopsychosocial perspective of ed. Unfortunately, there is a dearth of literature describing the components of a biopsychosocial program designed for the post-rp population and their partners.Results In this paper, we detail the development of the Prostate Cancer Rehabilitation Clinic (pcrc), which emphasizes multidisciplinary intervention teams, active participation by the partner, and a broad-spectrum medical, psychological, and interpersonal approach.Conclusions The goal of the pcrc is to help patients and their partners achieve optimal sexual health and couple intimacy after rp, and to help design cost-effective and beneficial rehabilitation programs.

show abstract

“…ADT is most commonly administered in the form of luteinizing hormone releasing hormone agonists (LHRHa) and is associated with many adverse effects that reduce the quality of life of prostate cancer patients ( 5 - 11 ). Our previous research has indicated a gap in patient knowledge about these adverse effects ( 12 ), which can influence patients’ ability to implement management strategies to mitigate these side effects. Tran et al .…”

Section: Introductionmentioning

confidence: 99%

“…Tran et al . ( 12 ) examined the perspectives of Canadian uro-oncologists on patient education about ADT side effects. They found considerable diversity among treating physicians about which side effects they felt were essential to inform patients about.…”

Section: Introductionmentioning

confidence: 99%

“…In contrast, there was strong agreement about informing patients about the following side effects: osteoporosis, erectile dysfunction, hot flashes, loss of libido, and loss of muscle mass. Respondents were also surveyed about side effect management strategies [reviewed in ( 13 )] they recommended to patients ( 12 ) and a lack of concordance was also observed for management strategies.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

What do urologists think patients need to know when starting on androgen deprivation therapy? The perspective from Canada versus countries with lower gross domestic product

Rot¹,

Wassersug²,

Walker³

2016

Transl. Androl. Urol.

View full text Add to dashboard Cite

BackgroundAndrogen deprivation therapy (ADT) side effects are numerous and negatively impact prostate cancer patients’ quality of life. There is considerable discrepancy though among Canadian urologists regarding what ADT side effects and side effect management strategies. Little is known about global differences in ADT patient education.MethodsInternational respondents were recruited via online posting and at an international urology conference. Hypotheses suggest that economic and cultural differences influence patient education practices; therefore, international respondents were divided into 3 categories (high, medium, and low gross domestic product).ResultsNo differences were found between responses from Canadian urologists and high GDP countries. Compared to responses from low GDP countries, Canadian urologists are more likely to endorse informing patients about: osteoporosis, loss of muscle mass, weight gain, fatigue/sleep disturbance, relationship changes, cognitive changes, and loss of body hair. Infertility was the only side effect more often disclosed by urologists in low GDP counties. Recommended management strategies for hot flashes are more likely to be pharmaceutical in Canada, and behavioral in low GDP countries. Management strategies for gynecomastia are emphasized more in low GDP countries. Physical exercise is endorsed consistently more often by Canadian urologists.ConclusionsADT educational practices vary greatly between Canada and lower GDP countries. Factors that could contribute to differences include economics (e.g., ADT drug costs), differences in side effect presentation due to different ADT drugs used, racial differences in perceived side effect burden, disease status at ADT commencement, and cultural differences in patient-physician shared-decision making.

show abstract

What do Canadian uro-oncologists believe patients should know about androgen deprivation therapy?

Cited by 16 publications

References 35 publications

Luteinizing Hormone–Releasing Hormone Agonists: A Quick Reference for Prevalence Rates of Potential Adverse Effects

Luteinizing Hormone–Releasing Hormone Agonists: A Quick Reference for Prevalence Rates of Potential Adverse Effects

The Prostate Cancer Rehabilitation Clinic: A Biopsychosocial Clinic for Sexual Dysfunction after Radical Prostatectomy

What do urologists think patients need to know when starting on androgen deprivation therapy? The perspective from Canada versus countries with lower gross domestic product

Contact Info

Product

Resources

About